임상약리학회지 (Journal of Korean Society for Clinical Pharmacology and Therapeutics)

대한임상약리학회 (Korean Society for Clinical Pharmacology and Therapeutics)
권호 표지

선진국에서 의약품사용평가의 발전과정과 현황

Background and Current Status of Drug Utilization Review in the Developed Countries

  • 이수정 (서울대학교병원 임상시험센터) ;
  • 박병주 (서울대학교 의과대학 예방의학교실,서울대학교병원 임상시험센터)
  • Lee, Soo-Jeong (Clinical Trial Center, Seoul National University Hospital) ;
  • Park, Byung-Joo (Department of Preventive Medicine, Seoul National University College of Medicine,Clinical Trial Center, Seoul National University Hospital)
  • 발행 : 1999.12.30

⟨ 이전 논문 다음 논문 ⟩

초록

The background, evolution, and current status of drug utilization review (DUR) in the developed countries is reviewed. DUR is defined as "an authorized, structured, and continuing program that reviews, analyzes, and interprets patterns of drug usage in a given health care delivery system against predetermined standards". DUR program has been developed to improve the quality of pharmaceutical care and promote cost-effectiveness of drug therapy. DUR provides feedback to physicians on the possibility of adverse effect of their prescription to the patients. DUR is classified retrospective, prospective, and concurrent according to the direction of implementation. Information systems and databases are essential to perform DUR program and DUR study. They could be used to enable physicians to develop more rational prescribing rules from population data that would improve the quality of pharmaceutical care.

키워드